中文在线：公司及控股子公司的担保总额为人民币约1.81亿元

Group 1 - The total guarantee amount of the company and its subsidiaries is approximately RMB 181 million, accounting for 17.96% of the latest audited net assets [1] - For the first half of 2025, the company's revenue composition is as follows: 98.62% from the cultural industry, 1.04% from the education industry, and 0.34% from other businesses [1] - The current market capitalization of the company is RMB 20.1 billion [1] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year [1] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is facing challenges in fundraising [1]